CONTINUE TO SITE

OR WAIT null SECS

COVID-19 Update Analytics Development Downstream Processing Manufacturing Outsourcing Quality/GMPs Upstream Processing

COVID-19 UpdateAnalyticsDevelopmentDownstream ProcessingManufacturingOutsourcingQuality/GMPsUpstream Processing

View More Analytical Methods BioBusiness Cell Culture/Fermentation Continuous Processing Drug Delivery Fill/Finish Formulation Process Chromatography Process Control/PAT Process Development QA/QC Separation and Purification Single-Use Systems Supply Chain

Analytical MethodsBioBusinessCell Culture/FermentationContinuous ProcessingDrug DeliveryFill/FinishFormulationProcess ChromatographyProcess Control/PATProcess DevelopmentQA/QCSeparation and PurificationSingle-Use SystemsSupply Chain

News

All News Top News Bio/Pharma News Industry News Supplier News Events

All NewsTop NewsBio/Pharma NewsIndustry NewsSupplier NewsEvents

Publications

All Publications BioPharm International

All PublicationsBioPharm International

Resources

Biopharma Insights Sponsored eBooks Sponsored Podcasts Sponsored Videos Whitepapers

Biopharma InsightsSponsored eBooksSponsored PodcastsSponsored VideosWhitepapers

Webcasts

Enews Magazine

EnewsMagazine

About Us
Advertise
Editorial Information
Contact Us
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Spotlight

COVID-19 Update
Analytics
Development
Downstream Processing
Manufacturing
Outsourcing
Quality/GMPs
Upstream Processing

TopicSee All >

Analytical Methods
BioBusiness
Cell Culture/Fermentation
Continuous Processing
Drug Delivery
Fill/Finish
Formulation
Process Chromatography
Process Control/PAT
Process Development
QA/QC
Separation and Purification
Single-Use Systems
Supply Chain

About Us
Advertise
Editorial Information
Contact Us
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Manufacturing

home

The Evolving Aseptic Processing Landscape

Single-use technologies allowed drug manufacturers to adapt to pandemic challenges.

Clean Factory Systems

Help prevent contamination in each of seven facility zones.

Pfizer Agrees to License Agreement with Voyager Therapeutics

October 08, 2021

Pfizer may pay up to $630 million for access to Voyager’s novel AAV capsids in transgene research.

Moderna to Select Site in Africa for $500 Million mRNA Facility

October 08, 2021

Moderna’s new facility is expected to produce 500 million vaccine doses per year.

NIIMBL Invests $3 Million in Six Biopharmaceutical Manufacturing Products

October 07, 2021

The $3 million investment will go towards various projects investigating key product attributes for therapeutic proteins.

MilliporeSigma Launches Excipient Platform for Protein-Based Therapies

October 06, 2021

New excipients for protein-based drug products reduce viscosity while maintaining protein stability.

Thermo Fisher Scientific Opens Biologics Manufacturing Site in Lengnau, Switzerland

October 04, 2021

Thermo Fisher’s new Swiss facility will initially produce CSL Limited’s recombinant factor IX product Idelvion.

Next-Gen Technologies Tackle Drug Delivery Challenges

October 02, 2021

The complexity of newer biotherapeutic molecules calls for alternative drug delivery strategies.

Getting a Nose for Vaccines

October 02, 2021

The intranasal route of administration is showing clinical promise, particularly for COVID-19, but there are multiple hurdles to overcome to ensure successful formulation.

Large-Scale Single-Use Bioreactors Prove Mettle Amid Growing Demand

October 02, 2021

Large-scale single-use bioreactors prove successful as limits are tested.

Limits and Successes Define Large-Scale SUBs Path

October 01, 2021

SUB bioreactor performance has had seen its limits and successes.

Designing a Control Strategy for Facilities with Single-Use Systems

October 01, 2021

Early control architecture decisions can impact a facility’s long-term growth, flexibility, and efficiency.